Lack of prognostic significance of survivin, survivin-deltaEx3, survivin-2B, galectin-3, bag-1, bax-alpha and MRP-1 mRNAs in breast cancer.

Cancer Lett 2003 Nov;201(2):225-36

National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.

The expression of transcripts for anti-apoptotic (survivin, survivin-deltaEx3, survivin-2B, galectin-3, bag-1 and bcl-2) and pro-apoptotic (bax-alpha) genes, and for multiple drug resistance related protein-1 (MRP-1) gene were investigated, using RT-PCR, in 106 breast tumour biopsies. Normal breast tissue was also analysed for comparative purposes. Overall, survivin, survivin-deltaEx3, survivin-2B, bcl-2, bag-1, galectin-3, bax-alpha and MRP-1 mRNAs were detected in 68, 54.7, 9.4, 78.4, 80.9, 98.9, 97.8 and 72.8%, respectively, of tumour specimens. Uniquely among the mRNAs analysed, the expression of bcl-2 correlated significantly with disease outcome, with bcl-2 expression indicative of favourable outcome in terms of both relapse-free survival and overall survival. This suggests that bcl-2 mRNA expression may be a key prognostic marker for breast cancer and that routine analysis of expression of this transcript should be considered. The results from this study suggest, however, that the expression of survivin, survivin-deltaEx3, survivin-2B, bag-1, galectin-3, bax-alpha and MRP-1 mRNAs cannot be considered as prognostic indicators of disease outcome for patients with breast cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0304-3835(03)00518-4DOI Listing
November 2003

Publication Analysis

Top Keywords

survivin survivin-deltaex3
16
survivin-deltaex3 survivin-2b
16
breast cancer
12
mrp-1 mrnas
12
bax-alpha mrp-1
12
bag-1 galectin-3
8
disease outcome
8
galectin-3 bax-alpha
8
survivin-2b galectin-3
8
galectin-3 bag-1
8
expression
6
bcl-2
5
breast
5
mrnas detected
4
prognostic marker
4
989 978
4
detected 547
4
809 989
4
784 809
4
biopsies normal
4

Altmetric Statistics

Similar Publications